Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/26/2025

Medication Management for Radiculopathy

First-Line Pharmacologic Approach

  • The American College of Physicians recommends gabapentin as the first-choice medication for radiculopathy, showing small to moderate short-term benefits specifically for radicular/sciatic pain 1, 2
  • Gabapentin dosing should be titrated up to 1200-3600 mg/day, though results were inconsistent across trials 1
  • The American Geriatrics Society suggests adjusting dosing in patients with renal impairment to avoid accumulation and toxicity 2
  • Monitoring for sedation, dizziness, and peripheral edema is necessary when using gabapentin 1
  • The FDA has not approved gabapentin specifically for low back pain with radiculopathy 1
  • Adding an NSAID, such as naproxen or ibuprofen, to gabapentin can target the inflammatory component of pain 1
  • Evidence from the Annals of Internal Medicine shows small and inconsistent effects on pain from NSAIDs alone for radiculopathy 3
  • The American Heart Association notes that NSAIDs increase cardiovascular risk with longer use and higher doses 1

Second-Line Options

  • Tizanidine is the preferred muscle relaxant for lumbar radiculopathy, with demonstrated efficacy in 8 trials for acute low back pain 4
  • The American Academy of Neurology recommends starting with 2-4 mg of tizanidine and titrating up as needed 4
  • Treatment with tizanidine should be limited to short-term use (7-14 days maximum) 4
  • Monitoring for hypotension and sedation, the most common dose-related adverse effects, is necessary when using tizanidine 4

Medications to AVOID

  • The American College of Physicians recommends avoiding systemic corticosteroids for radicular low back pain, as six trials consistently found no differences between systemic corticosteroids and placebo in pain relief 5
  • The Annals of Internal Medicine notes that oral prednisone increased risk for adverse events without providing benefit 5
  • Benzodiazepines should be avoided, as they are associated with no difference in function but more pain compared to placebo for radiculopathy, and carry risks of abuse, addiction, and tolerance 5, 1
  • Pregabalin has inconsistent results for radiculopathy and may actually worsen function 5, 2

Treatment Algorithm

  • Initiate gabapentin (start low, titrate to 1200-3600 mg/day) for the neuropathic component, and add an NSAID for the inflammatory component 1, 2
  • For acute severe pain, consider adding tizanidine 2-4 mg for short-term use (≤2 weeks) 4
  • If insufficient response after 2-4 weeks, consider adding a tricyclic antidepressant or duloxetine 1
  • Reassess efficacy and side effects regularly, and discontinue medications that are not providing benefit 1

Evidence‑Based Recommendations for Muscle‑Relaxant Use in Patients with Atrial Fibrillation on Anticoagulation

Pharmacologic Pain Management

  • Duloxetine provides modest benefits for chronic low‑back pain with a neuropathic component, supported by moderate‑quality evidence. (American Society of Internal Medicine) 6

Drug‑Interaction and Safety Considerations

  • There are no direct contraindications between muscle‑relaxants and beta‑blockers or apixaban; however, clinicians should monitor for additive hypotension, especially when titrating tizanidine. (American College of Cardiology) [7][8]

REFERENCES

1

Alternative Medications for Sciatica and Chronic Back Pain [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Chronic Low Back Pain [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Medication Selection for Lumbar Radiculopathy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025